QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 essa-pharma-received-an-amended-interim-order-from-the-supreme-court-of-british-columbia-on-september-25-2025-the-amended-interim-order-approves-the-previously-announced-date-for-essas-special-meeting-of-the-holders-of-common-shares-of-the-company-optionholders-and-warrantholders-of-october-3-2025

SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC, Sept. 30, 2025 /PRNewswire/ -- ESSA Pharma Inc. ("ESSA," or the "Com...

Core News & Articles

Shareholders expected to receive approximately $0.12 per share in cash upon closing of transaction and up to approximately $0.1...

 essa-pharma-confirms-80m-capital-distribution-paid-august-22-shares-began-trading-ex-dividend-august-25-after-correcting-due-bill-period

ESSA Pharma Inc. ("ESSA," or the "Company") (NASDAQ:EPIX) announced on August 14, 2025 that, in connection with...

 essa-pharma-q3-eps-009-beats-016-estimate

ESSA Pharma (NASDAQ:EPIX) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.16) b...

 essa-pharma-to-distribute-80m-to-shareholders

SOUTH SAN FRANCISCO, Calif and VANCOUVER, Canada, Aug. 6, 2025 /PRNewswire/ -- ESSA Pharma Inc. ("ESSA," or the "Co...

 essa-pharma-to-seek-court-approval-for-shareholder-payout-and-special-meeting-ahead-of-acquisition-by-xenotherapeutics

 ESSA Pharma Inc. ("ESSA," or the "Company") (NASDAQ:EPIX) today announced that, in connection with its previou...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION